SEC Filings

    Filing date Form Description Filing Group View
    F-4/A

    Amendment to a previously filed F-4
    Registration Statements
    		 View HTML
    0001104659-23-010230.pdf
    0001104659-23-010230.rtf
    0001104659-23-010230.xls
    CORRESP

    CORRESP
    Other
    		 View HTML
    0001104659-23-009560.pdf
    0001104659-23-009560.rtf
    0001104659-23-009560.xls
    F-4/A

    Amendment to a previously filed F-4
    Registration Statements
    		 View HTML
    0001104659-23-006384.pdf
    0001104659-23-006384.rtf
    0001104659-23-006384.xls
    CORRESP

    CORRESP
    Other
    		 View HTML
    0001104659-23-006388.pdf
    0001104659-23-006388.rtf
    8-A12B

    Registration of certain classes of securities 12(b) of the Securities Exchange Act
    Registration Statements
    		 View HTML
    0001104659-23-005236.pdf
    0001104659-23-005236.rtf
    0001104659-23-005236.xls
    UPLOAD

    UPLOAD
    Other
    		 View HTML
    0000000000-23-000560.pdf
    0000000000-23-000560.rtf
    F-4/A

    Amendment to a previously filed F-4
    Registration Statements
    		 View HTML
    0001104659-23-003636.pdf
    0001104659-23-003636.rtf
    0001104659-23-003636.xls
    CORRESP

    CORRESP
    Other
    		 View HTML
    0001104659-23-003637.pdf
    0001104659-23-003637.rtf
    UPLOAD

    UPLOAD
    Other
    		 View HTML
    0000000000-23-000192.pdf
    0000000000-23-000192.rtf
    F-4

    Registration statement for foreign private issuers issued in certain business transactions
    Registration Statements
    		 View HTML
    0001104659-22-130315.pdf
    0001104659-22-130315.rtf
    0001104659-22-130315.xls
    Displaying 51 - 60 of 71 results

    Data provided by Kaleidoscope.

    Print Page
    Email Alerts
    RSS Feeds
    Contact IR
    Site Map Terms of Use Privacy

    Contact Info

    YS Biopharma Co., Ltd.

    11 Firstfield Road Suite A
    Gaithersburg, Maryland 20878 USA

    Tel: +1 (301) 208 8823
    Fax: +1 (301) 208 8827

    bjinfo@yishengbio.com